Men Health

Creatine supplementation has gained widespread attention in the fitness and health communities due to its well-documented benefits. Regular daily doses of creatine have been shown to enhance muscular strength, support…

A West Midlands police officer has credited a colleague and a joint Federation and Force prostate health campaign for saving his life after an early diagnosis of prostate cancer. The…

A recent investigation analyzed 23 protein powders and ready-to-drink shakes sold in the United States. Findings revealed that more than two-thirds of these products contained lead levels exceeding what experts…

Prostate cancer continues to be the second most frequently diagnosed cancer among men worldwide and ranks as the fifth leading cause of cancer-related death. Risk factors include advancing age, family…

Prostate-specific antigen (PSA) screening has been shown to reduce prostate cancer mortality by 13% over a median follow-up of 23 years, according to the latest analysis from the European Randomized…

The NHS has initiated a pioneering trial that could reduce prostate cancer diagnosis times from several weeks to just a single day. The initiative employs artificial intelligence to analyze MRI…

The prostate-specific antigen (PSA) test is a diagnostic blood test that measures the concentration of PSA, a protein produced by the prostate gland. Elevated PSA levels can indicate various prostate-related…

Scientists at Sanford Burnham Prebys’ NCI-Designated Cancer Center have uncovered critical differences in how pancreatic cancer progresses in older versus younger organisms, offering new insights for developing age-appropriate treatments. Published…

A new analysis of the landmark Systolic Blood Pressure Intervention Trial (SPRINT) reveals that intensive blood pressure control (target <120 mmHg) provides net clinical benefits for nearly all adults with…

Scientists at Oregon State University have patented a novel magnetic resonance imaging (MRI) contrast agent design that demonstrates potential to outperform current clinical standards while offering reduced patient toxicity and…

Prostate cancer remains the most frequently diagnosed malignant tumor among men worldwide. In a recent episode of Hadassah On Call, Dr. Ofer Gofrit, chair of the Urology Department at the…

Prostate cancer cases have surged dramatically in Korea, with over 20,000 new diagnoses reported in 2022, according to the National Cancer Center. The disease now represents 7.4 percent of all…

Most diets are designed to fail because they often rely on extreme restrictions that are difficult to sustain long term. While cutting calories, fats, or sugars may lead to short-term…

Whether you’re managing a buzz cut, trimming your beard, or cleaning up the edges before your next barber visit, choosing the right clippers can transform your grooming routine. After weeks…

At Shaving Advisor, we dedicate ourselves to rigorous and professional testing of beard trimmers. Each model undergoes extensive hands-on evaluation to ensure accuracy, performance, and user satisfaction. However, we understand…

Going to the bathroom is a normal part of daily life, but when the urge to urinate becomes constant, even after you’ve emptied your bladder, it may signal an underlying…

This past summer, I was diagnosed with prostate cancer. For more than three decades, I have taught, examined, and guided patients through various types of illnesses. However, nothing prepared me…

Shilajit may influence testosterone levels and male fertility, while also exhibiting anti-inflammatory, antioxidant, and adaptogenic properties. Evidence supporting these effects is mixed, with limited human research and gaps in safety…

Here is a professionally rewritten article in HTML format with subheadings, preserving the original meaning while improving structure and clarity. Two short headlines based on real data and health are…

The combination of leuprolide and enzalutamide demonstrates a substantial survival benefit for men with locally advanced or recurrent high-risk prostate cancer, according to the multinational EMBARK phase III trial. Researchers…